2025-05-29 - Analysis Report
Okay, here's a report based on the provided data, designed to be concise and informative.

**Report on Newmont Corporation (NEM)**

**Newmont Corporation is the world's leading gold company and a producer of copper, silver, zinc and lead.**

**1. Performance vs. S&P 500 (VOO)**

*   **Key Metrics:**
    *   NEM Cumulative Return: 25.37%
    *   VOO Cumulative Return: 82.09%
    *   Return Difference: -56.7%
    *   Relative Deviation: 12.5
    *   Deviation Range (Max: 88.6, Min: -77.5)

*   **Analysis:** NEM has significantly underperformed the S&P 500 over the analyzed period. The negative return difference indicates a substantial gap in performance. A relative deviation of 12.5 suggests it is still closer to its worst underperformance range than outperformance.

*   **Alpha, Beta Analysis:**

| Year       | CAGR    | MDD   | Alpha   | Beta  | Cap(B) |
|------------|---------|-------|---------|-------|--------|
| 2015-2017  | 33.0%   | 26.5% | 4.0%    | 0.0   | 33.3   |
| 2016-2018  | 17.0%   | 58.8% | -1.0%   | -0.0  | 31.3   |
| 2017-2019  | -2.0%   | 58.8% | -31.0%  | -0.1  | 40.8   |
| 2018-2020  | 34.0%   | 58.8% | 9.0%    | 0.0   | 57.3   |
| 2019-2021  | 71.0%   | 59.9% | 17.0%   | 0.1   | 61.5   |
| 2020-2022  | -16.0%  | 64.3% | -22.0%  | 0.2   | 48.7   |
| 2021-2023  | -42.0%  | 71.4% | -59.0%  | 0.6   | 44.5   |
| 2022-2024  | -70.0%  | 75.3% | -87.0%  | 0.7   | 41.0   |
| 2023-2025  | -18.0%  | 75.3% | -48.0%  | 1.2   | 58.8   |

*   **Analysis:** The Alpha/Beta analysis reveals a concerning trend. While Beta values are generally low, suggesting NEM is less volatile than the market, the Alpha values are consistently negative, indicating NEM has underperformed relative to its risk level, especially in recent years. High MDD values are also concerning.

**2. Recent Price Action**

*   **Price:** $52.85
*   **Previous Close:** $52.71
*   **Change:** $0.27
*   **5-day Moving Average:** 52.75
*   **20-day Moving Average:** 51.85
*   **60-day Moving Average:** 49.70

*   **Analysis:** The stock price is currently slightly above its 5-day and 20-day moving averages, indicating a short-term upward trend. It's also significantly above the 60-day moving average, suggesting a potential medium-term recovery or continued upward momentum. The recent price change of $0.27 is not substantial enough to indicate a major volatility event.

**3. Technical Indicators & Outlook**

*   **Market Risk Indicator (MRI):** 0.37 (Low Risk)
*   **RSI:** 46.68 (Neutral)
*   **PPO:** 0.15 (Neutral)
*   **Hybrid Signal:** cash_1%_Buy 80% of cash (71 shares - Caution - MRI:0.37)
*   **20-day Relative Deviation Change:** 0.5 (+): Short-term increase
*   **Expected Return:** -139.6% (Long-Term, vs. S&P 500)

*   **Analysis:**
    *   The MRI suggests a low-risk environment, which is contradictory to NEM's historical performance.
    *   RSI and PPO are neutral, indicating no strong overbought or oversold conditions.
    *   The Hybrid Signal suggests a cautious buying opportunity with 80% of available cash, with a strong caution.
    *   The short-term increase in relative deviation is a slightly positive sign, but the extremely negative expected return raises serious concerns about long-term investment potential.

**4. Recent News & Events**

*   **Summary:** Recent news indicates potential volatility, analyst discussions around performance, and market events impacting NEM.

*   **Implication:** Investors should closely monitor news and company announcements to understand the drivers of the recent volatility.

**5. Recent Earnings Analysis**

| Date       | EPS  | Revenue     |
|------------|------|-------------|
| 2025-04-24 | 1.68 | 5.01 B$     |
| 2024-10-24 | 0.8  | 4.61 B$     |
| 2024-07-25 | 0.74 | 4.40 B$     |
| 2024-04-29 | 0.15 | 4.02 B$     |
| 2025-04-24 | 0.15 | 4.02 B$     |

*   **Analysis:** The most recent EPS spiked significantly and the revenues have been increasing steadily.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-03-31 | $5.01B | 46.13%        |
| 2024-12-31 | $5.65B | 45.51%        |
| 2024-09-30 | $4.61B | 36.13%        |
| 2024-06-30 | $4.40B | 37.35%        |
| 2024-03-31 | $4.02B | 31.39%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE    |
|------------|-----------|--------|
| 2025-03-31 | $31.25B  | 6.05%  |
| 2024-12-31 | $29.93B  | 4.69%  |
| 2024-09-30 | $29.71B  | 3.10%  |
| 2024-06-30 | $29.38B  | 2.90%  |
| 2024-03-31 | $28.89B  | 0.59%  |

*   **Analysis:** Revenue and profit margins have been trending upwards, especially in the most recent quarters. Equity has also increased, leading to improved ROE. This indicates improving financial health, but it doesn't align with the recent performance decline versus the S&P 500.

**7. Overall Summary**

Newmont Corporation (NEM) exhibits a mixed picture. While recent financial performance (revenue, profit margin, ROE, and EPS) is improving, NEM has significantly underperformed the S&P 500, with a strongly negative expected return. Technical indicators are mixed, and analyst discussions point to volatility.

*   **Key Concerns:**
    *   Significant underperformance compared to the S&P 500.
    *   Negative expected return for long-term investment.
    *   Recent volatility.
    *   High MDD values.
*   **Potential Positives:**
    *   Improving revenue and profit margins.
    *   Low MRI indicating a low-risk market environment.
    *   Short-term upward price trend.

**Recommendation:**

Given the conflicting signals, a cautious approach is warranted. Further research into the drivers of underperformance and careful monitoring of news and earnings reports are essential. The potential buying opportunity suggested by the Hybrid Signal should be approached with a low allocation due to the significant uncertainty surrounding NEM's future performance.
